KKM Financial LLC Has $63,000 Position in ASP Isotopes Inc. (NASDAQ:ASPI)

KKM Financial LLC lifted its holdings in ASP Isotopes Inc. (NASDAQ:ASPI) by 66.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,600 shares of the company’s stock after buying an additional 9,000 shares during the period. KKM Financial LLC’s holdings in ASP Isotopes were worth $63,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in ASP Isotopes in the 3rd quarter worth about $6,249,000. Telemark Asset Management LLC purchased a new stake in shares of ASP Isotopes in the third quarter worth approximately $4,726,000. Vanguard Group Inc. boosted its holdings in shares of ASP Isotopes by 479.1% during the first quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after purchasing an additional 844,705 shares during the period. Marshall Wace LLP grew its position in ASP Isotopes by 389.6% during the second quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock valued at $1,668,000 after purchasing an additional 433,734 shares in the last quarter. Finally, GSA Capital Partners LLP grew its position in ASP Isotopes by 96.0% during the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after purchasing an additional 377,721 shares in the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on ASPI shares. HC Wainwright cut their target price on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 price objective on shares of ASP Isotopes in a report on Friday, October 18th. Finally, Canaccord Genuity Group assumed coverage on ASP Isotopes in a research report on Friday, October 4th. They set a “buy” rating and a $4.50 price objective for the company.

ASP Isotopes Stock Up 8.2 %

NASDAQ ASPI opened at $8.34 on Friday. The company has a current ratio of 7.55, a quick ratio of 4.00 and a debt-to-equity ratio of 0.80. ASP Isotopes Inc. has a 12-month low of $1.65 and a 12-month high of $9.33. The company has a 50 day moving average price of $4.84 and a two-hundred day moving average price of $3.82.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.